These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2759923)

  • 1. Roxithromycin in the treatment of pneumonia.
    Peterslund NA; Hänninen P; Schreiner A; Black FT; Hultén V
    J Antimicrob Chemother; 1989 May; 23(5):737-41. PubMed ID: 2759923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia.
    Poirier R
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():109-16. PubMed ID: 1827096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roxithromycin, a new macrolide antibiotic, in the treatment of infections in the lower respiratory tract: an overview.
    Gentry LO
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():145-52. PubMed ID: 3323166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Roxithromycin in the treatment of community-acquired pneumonia].
    Antela A; Guerrero A; Montilla P; Hermida JM; Fortún J; Pérez Elías MJ; Quereda C; Navas E
    Enferm Infecc Microbiol Clin; 1993 May; 11(5):260-2. PubMed ID: 8324023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contradiction between in vitro and clinical outcome: intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia.
    Kohno S; Tateda K; Kadota J; Fujita J; Niki Y; Watanabe A; Nagashima M
    J Infect Chemother; 2014 Mar; 20(3):199-207. PubMed ID: 24477328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open evaluation of the efficacy and safety of the new macrolide roxithromycin in the treatment of lower respiratory tract infections and pneumonia in Nigerian patients.
    Isah AO; Ohaju-Obodo J
    West Afr J Med; 1996; 15(2):111-6. PubMed ID: 8855675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Roxithromycin (RU 28965), a new macrolide effective against pulmonary infections].
    Lachat JM; Anex JF; Regamey C
    Schweiz Med Wochenschr; 1986 Dec; 116(49):1739-41. PubMed ID: 3810100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.
    Young RA; Gonzalez JP; Sorkin EM
    Drugs; 1989 Jan; 37(1):8-41. PubMed ID: 2651088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roxithromycin alone and in combination with sulphamethoxazole against Haemophilus influenzae.
    Lapointe JR; Lavallée C; Meilleur R; Bourget C
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():21-9. PubMed ID: 3501425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzylpenicillin versus wide-spectrum beta-lactam antibiotics as empirical treatment of Haemophilus influenzae-associated lower respiratory tract infections in adults; a retrospective propensity score-matched study.
    Thegerström J; Månsson V; Riesbeck K; Resman F
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1761-1775. PubMed ID: 29961165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Microbiological, pharmacokinetic and clinical studies of rokitamycin dry syrup in the pediatric field].
    Motohiro T; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Fujimoto T; Sakata Y; Yamashita F; Suzuki K
    Jpn J Antibiot; 1988 Jul; 41(7):920-59. PubMed ID: 3050186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nontypeable Haemophilus influenzae in the elderly.
    Berk SL; Holtsclaw SA; Wiener SL; Smith JK
    Arch Intern Med; 1982 Mar; 142(3):537-9. PubMed ID: 6978116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae.
    Kuenzi B; Segessenmann C; Gerber AU
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():39-46. PubMed ID: 3501426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-acquired Haemophilus influenzae pneumonia--New insights from the CAPNETZ study.
    Forstner C; Rohde G; Rupp J; Schuette H; Ott SR; Hagel S; Harrison N; Thalhammer F; von Baum H; Suttorp N; Welte T; Pletz MW;
    J Infect; 2016 May; 72(5):554-63. PubMed ID: 26940505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide, multicenter survey on the efficacy and safety of piperacillin for adult community-acquired pneumonia in Japan.
    Yamamoto Y; Watanabe A; Goto H; Matsushima T; Abe S; Aoki N; Shimokata K; Mikasa K; Niki Y; Kohno S
    J Infect Chemother; 2012 Aug; 18(4):544-51. PubMed ID: 22618270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients.
    Lieberman D; Schlaeffer F; Boldur I; Lieberman D; Horowitz S; Friedman MG; Leiononen M; Horovitz O; Manor E; Porath A
    Thorax; 1996 Feb; 51(2):179-84. PubMed ID: 8711652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxifloxacin pharmacokinetic profile and efficacy evaluation in empiric treatment of community-acquired pneumonia.
    Öbrink-Hansen K; Hardlei TF; Brock B; Jensen-Fangel S; Kragh Thomsen M; Petersen E; Kreilgaard M
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2398-404. PubMed ID: 25666151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia.
    Ohno A; Ishii Y; Kobayashi I; Yamaguchi K
    J Infect Chemother; 2007 Oct; 13(5):296-301. PubMed ID: 17982717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pleuropulmonary lesions due to Haemophilus influenzae].
    González N; Arredondo JL; Calderón E; Hernández M; Cob C
    Bol Med Hosp Infant Mex; 1977; 34(1):59-70. PubMed ID: 300024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.